Učitavanje...
Impact of telmisartan in modifying vascular risk
Telmisartan, a selective angiotensin II type 1 receptor blocker (ARB), has been investigated in many trials, in particular, in order to assess its antihypertensive effect in various situations and its ability to protect organs susceptible to hypertension. In addition to its antihypertensive properti...
Spremljeno u:
Glavni autori: | , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Dove Medical Press
2010
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3172066/ https://ncbi.nlm.nih.gov/pubmed/21949624 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|